Abstract
The antistaphylococcal activity of ceftobiprole was compared with those of cefuroxime, linezolid, and moxifloxacin by using the agar dilution method. Apart from three strains with small-colony variant phenotypes, all Staphylococcus aureus isolates tested were inhibited by < or =2 microg/ml of ceftobiprole. This compound exhibited an excellent antistaphylococcal activity, comparable to that of linezolid.
MeSH terms
-
Acetamides / pharmacology
-
Anti-Bacterial Agents / pharmacology*
-
Aza Compounds / pharmacology
-
Cefuroxime / pharmacology
-
Cephalosporins / pharmacology*
-
Fluoroquinolones
-
Genetic Variation*
-
Linezolid
-
Microbial Sensitivity Tests
-
Moxifloxacin
-
Oxazolidinones / pharmacology
-
Phenotype*
-
Quinolines / pharmacology
-
Staphylococcal Infections / drug therapy*
-
Staphylococcal Infections / microbiology
-
Staphylococcus / drug effects*
-
Staphylococcus / genetics
-
Staphylococcus / isolation & purification
Substances
-
Acetamides
-
Anti-Bacterial Agents
-
Aza Compounds
-
Cephalosporins
-
Fluoroquinolones
-
Oxazolidinones
-
Quinolines
-
ceftobiprole
-
Linezolid
-
Cefuroxime
-
Moxifloxacin